Literature DB >> 17097983

Cancers of new appearance in liver transplant recipients: incidence and evolution.

M E Romero-Vargas1, M Flores-Cortés, Z Valera, M A Gómez-Bravo, L Barrera-Pulido, F Pareja-Ciuró, J Serrano Díez-Canedo, I García, A Bernardos.   

Abstract

OBJECTIVE: To investigate the incidence, time of appearance, treatment, and evolution of tumors appearing in liver transplant recipients at our hospital.
MATERIAL AND METHODS: We undertook a retrospective analysis of our series of liver transplants between 1990 and 2005. Patients who died during the immediate postoperative period were excluded.
RESULTS: Of the 515 patients, 25 died during the immediate postoperative period and therefore had no occasion to develop neoplasms. Of the remaining 490, 32 developed cancers (6.5%). The average age was 55.4 +/- 7.17 years. The reasons for transplant were alcoholic cirrhosis (n = 15), hepatitis C virus (2), hepatitis B virus (n = 1), alcoholic and viral cirrhosis (n = 7), primary biliary cirrhosis (n = 1), and cryptogenic cirrhosis (n = 1). Four patients developed multiple neoplasms. Most of the tumors were cutaneous: nine basal cell and six squamous cell carcinomas. Other locations were the lung, urothelium, stomach, thyroid, and brain. Eight patients presented metastasis at the time of diagnosis. The average tumor-free period was 3.36 years. Nine patients died as a result of the tumor. DISCUSSION: Patients with a liver transplant have a high risk of developing cancers as a result of the immunosuppression treatment, which is lifelong. Nevertheless, other factors can be involved, such as infection by cytomegalovirus or the original diagnosis leading to transplantation. The risk for developing cancers is significantly greater than in the general population, with a higher tendency to recurrence and later development of second neoplasms.

Entities:  

Mesh:

Year:  2006        PMID: 17097983     DOI: 10.1016/j.transproceed.2006.08.028

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

1.  De novo malignancy after liver transplantation: a single-center experience of 14 cases.

Authors:  Peng Ji Gao; Jie Gao; Zhao Li; Zhi Ping Hu; Ji Ye Zhu
Journal:  Ann Surg Treat Res       Date:  2015-03-26       Impact factor: 1.859

Review 2.  Subsequent malignant neoplasms after hematopoietic cell transplantation.

Authors:  Gerard Socié; K Scott Baker; Smita Bhatia
Journal:  Biol Blood Marrow Transplant       Date:  2012-01       Impact factor: 5.742

3.  Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men.

Authors:  Umberto Maggi; Dario Consonni; Matteo Angelo Manini; Stefano Gatti; Francesco Cuccaro; Francesca Donato; Grazia Conte; Pier Alberto Bertazzi; Giorgio Rossi
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

4.  Lessons Learned From a Case of Gastric Cancer After Liver Transplantation for Hepatocellular Carcinoma: A Case Report and Literatures Review.

Authors:  Kun Yang; Hong Zhu; Chong-Cheng Chen; Tian-Fu Wen; Wei-Han Zhang; Kai Liu; Xin-Zu Chen; Dong-Jiao Guo; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.